Artykuły w czasopismach: „Interleukin-6”

1

&NA;. "Interleukin-3/interleukin-6". Reactions Weekly &NA;, nr 550 (maj 1995): 11. http://dx.doi.org/10.2165/00128415-199505500-00035.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

2

&NA;. "Interleukin-6". Reactions Weekly &NA;, nr 570 (wrzesień 1995): 9. http://dx.doi.org/10.2165/00128415-199505700-00023.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

3

Lotz, Martin. "Interleukin-6". Cancer Investigation 11, nr 6 (styczeń 1993): 732–42. http://dx.doi.org/10.3109/07357909309046948.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

4

&NA;. "Interleukin 6". Inpharma Weekly &NA;, nr 877 (marzec 1993): 2. http://dx.doi.org/10.2165/00128413-199308770-00001.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

5

&NA;. "Interleukin 6". Reactions Weekly &NA;, nr 505 (czerwiec 1994): 8. http://dx.doi.org/10.2165/00128415-199405050-00037.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

6

&NA;. "Interleukin 6". Reactions Weekly &NA;, nr 531 (grudzień 1994): 8. http://dx.doi.org/10.2165/00128415-199405310-00027.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

7

Song, Mingchen, i John A. Kellum. "Interleukin-6". Critical Care Medicine 33, Suppl (grudzień 2005): S463—S465. http://dx.doi.org/10.1097/01.ccm.0000186784.62662.a1.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

8

CASTELL, JOSé V., TILO ANDUS, DIETER KUNZ i PETER C. HEINRICH. "Interleukin-6". Annals of the New York Academy of Sciences 557, nr 1 (28.06.2008): 87–101. http://dx.doi.org/10.1111/j.1749-6632.1989.tb24001.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

9

LEE, FRANK, CHOY-PIK CHIU, JANUSZ WIDEMAN, PHILLIP HODGKIN, SUSAN HUDAK, LOUISE TROUTT, THERESA NG i in. "Interleukin-6". Annals of the New York Academy of Sciences 557, nr 1 (28.06.2008): 215–29. http://dx.doi.org/10.1111/j.1749-6632.1989.tb24015.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

10

CLARK, STEVEN C. "Interleukin-6". Annals of the New York Academy of Sciences 557, nr 1 (28.06.2008): 438–43. http://dx.doi.org/10.1111/j.1749-6632.1989.tb24036.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

11

Olencki, Thomas, James Finke i Ronald M. Bukowski. "Interleukin-6". Clinical Immunotherapeutics 2, nr 4 (październik 1994): 278–94. http://dx.doi.org/10.1007/bf03258528.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

12

Sin, Don D., i S. F. Paul Man. "Interleukin-6". Chest 133, nr 1 (styczeń 2008): 4–6. http://dx.doi.org/10.1378/chest.07-2085.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

13

Delk, Nikki A., i Mary C. Farach-Carson. "Interleukin-6". Autophagy 8, nr 4 (kwiecień 2012): 650–63. http://dx.doi.org/10.4161/auto.19226.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

14

Matsuda, Tadashi, i Toshio Hirano. "Interleukin 6 (IL-6)". Biotherapy 2, nr 4 (październik 1990): 363–73. http://dx.doi.org/10.1007/bf02170085.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

15

Rivera-Chavez, Fernando A., Dixie L. Peters-Hybki, Robert C. Barber i Grant E. O'Keefe. "Interleukin-6 Promoter Haplotypes and Interleukin-6 Cytokine Responses". Shock 20, nr 3 (wrzesień 2003): 218–23. http://dx.doi.org/10.1097/00024382-200309000-00004.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

16

Ridker, Paul M. "Targeting Interleukin-1 and Interleukin-6". Journal of the American College of Cardiology 76, nr 15 (październik 2020): 1774–76. http://dx.doi.org/10.1016/j.jacc.2020.08.052.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

17

NORTHEMANN, WOLFGANG, TODD A. BFUCIAK, MASAHIRA HATTORI i GEORG H. FEY. "Rat Interleukin-6". Annals of the New York Academy of Sciences 557, nr 1 (28.06.2008): 536–39. http://dx.doi.org/10.1111/j.1749-6632.1989.tb24057.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

18

Schneider, Kirsten, Reinhard Klaas, Bernd Kaspers i Peter Staeheli. "Chicken interleukin-6". European Journal of Biochemistry 268, nr 15 (1.08.2001): 4200–4206. http://dx.doi.org/10.1046/j.1432-1327.2001.02334.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

19

Tamura, T., N. Udagawa, N. Takahashi, C. Miyaura, S. Tanaka, Y. Yamada, Y. Koishihara, Y. Ohsugi, K. Kumaki i T. Taga. "Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6." Proceedings of the National Academy of Sciences 90, nr 24 (15.12.1993): 11924–28. http://dx.doi.org/10.1073/pnas.90.24.11924.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

20

Ogawa, Michio, Kiyoshi Sakamoto, Seiji Mita, Takatoshi Ishiko i Saburo Hisano. "INTERLEUKIN-6 AND SOLUBLE INTERLEUKIN-6 RECEPTOR IN SURGICAL TRAUMA". Shock 4, Supplement (grudzień 1995): 11. http://dx.doi.org/10.1097/00024382-199512001-00045.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

21

De Filippo, G., D. Rendina, F. Moccia, V. Rocco i A. Campanozzi. "Interleukin-6, soluble interleukin-6 receptor/interleukin-6 complex and insulin resistance in obese children and adolescents". Journal of Endocrinological Investigation 38, nr 3 (23.09.2014): 339–43. http://dx.doi.org/10.1007/s40618-014-0176-4.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

22

Oka, Masaaki, Hiroshi Kusanagi, Toshihiro Saeki, Norio Iizuka, Hiroto Hayashi, Akira Tangoku, Takuo Murakami i Takashi Suzuki. "Interleukin-6 Production and Interleukin-6 Receptor Expression in Human Esophageal Cancer Cell Lines". Japanese Journal of Gastroenterological Surgery 26, nr 11 (1993): 2707. http://dx.doi.org/10.5833/jjgs.26.2707.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

23

Prens, Errol P., Klazina Benne, Jozef van Damme, Marleen Bakkus, Karin Brakel, Robbert Benner i Theodoor van Joost. "Interleukin-1 and Interleukin-6 in Psoriasis". Journal of Investigative Dermatology 95, nr 6 (grudzień 1990): S121—S124. http://dx.doi.org/10.1111/1523-1747.ep12874991.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

24

Bota, Rafaqat, i Mushtaq Ahmed. "The pathophysiological profile of interleukin-6 and anti-interleukin-6 antibody". El Mednifico Journal 1, nr 2 (6.07.2013): 51. http://dx.doi.org/10.18035/emj.v1i2.26.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

25

Ridker, Paul M., i Manas Rane. "Interleukin-6 Signaling and Anti-Interleukin-6 Therapeutics in Cardiovascular Disease". Circulation Research 128, nr 11 (28.05.2021): 1728–46. http://dx.doi.org/10.1161/circresaha.121.319077.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Streszczenie:

IL (interleukin)-6 is a pivotal cytokine of innate immunity, which enacts a broad set of physiological functions traditionally associated with host defense, immune cell regulation, proliferation, and differentiation. Following recognition of innate immune pathways leading from the NLRP3 (NOD-, LRR-, and pyrin domain-containing protein 3) inflammasome to IL-1 to IL-6 and on to the hepatically derived clinical biomarker CRP (C-reactive protein), an expanding literature has led to understanding of the proatherogenic role for IL-6 in cardiovascular disease and thus the potential for IL-6 inhibition as a novel method for vascular protection. In this review, we provide an overview of the mechanisms by which IL-6 signaling occurs and how that impacts upon pharmacological inhibition; describe murine models of IL-6 and atherogenesis; summarize human epidemiological data outlining the utility of IL-6 as a biomarker of vascular risk; outline genetic data suggesting a causal role for IL-6 in systemic atherothrombosis and aneurysm formation; and then detail the potential role of IL-6 inhibition in stable coronary disease, acute coronary syndromes, heart failure, and the atherothrombotic complications associated with chronic kidney disease and end-stage renal failure. Finally, we review anti-inflammatory and antithrombotic findings for ziltivekimab, a novel IL-6 ligand inhibitor being developed specifically for use in atherosclerotic disease and poised to be tested formally in a large-scale cardiovascular outcomes trial focused on individuals with chronic kidney disease and elevated levels of CRP, a population at high residual atherothrombotic risk, high residual inflammatory risk, and considerable unmet clinical need.

26

Jucker, M., H. Abts, W. Li, R. Schindler, H. Merz, A. Gunther, C. von Kalle, M. Schaadt, T. Diamantstein i AC Feller. "Expression of interleukin-6 and interleukin-6 receptor in Hodgkin's disease". Blood 77, nr 11 (1.06.1991): 2413–18. http://dx.doi.org/10.1182/blood.v77.11.2413.2413.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Streszczenie:

Abstract Interleukin-6 (IL-6) is a multipotent lymphokine that can mediate differentiation of B cells into Ig-secreting cells, stimulate the growth of plasmacytomas, hybridomas, and T cells, and induce acute- phase proteins in liver cells. It has been suggested that IL-6 is involved in the pathogenesis of several diseases by autocrine or paracrine pathways. To examine whether IL-6 is possibly involved in the pathophysiology of Hodgkin's disease (HD), we analyzed the expression of IL-6 and IL-6 receptor mRNA and protein in cell lines and primary specimens from patients with HD. IL-6-specific transcripts were detected in three of six HD-derived cell lines by Northern blot analysis. In the culture supernatants of four HD-derived cell lines, IL- 6 was detected by radioimmunoassay. Biologic activity of IL-6 was confirmed by proliferation of an IL-6-dependent cell line. In situ hybridization experiments showed IL-6-specific transcripts in Hodgkin (H) and Reed-Sternberg (RS) cells in primary tissues of two patients. In addition, mRNAs specific for the IL-6 receptor were detected in five HD-derived cell lines. Immunostaining experiments showed expression of IL-6 receptor molecules on H and RS cells in 8 of 16 cases with HD. Thus, our data suggest that IL-6 might be involved in the pathophysiology of HD.

27

Jucker, M., H. Abts, W. Li, R. Schindler, H. Merz, A. Gunther, C. von Kalle, M. Schaadt, T. Diamantstein i AC Feller. "Expression of interleukin-6 and interleukin-6 receptor in Hodgkin's disease". Blood 77, nr 11 (1.06.1991): 2413–18. http://dx.doi.org/10.1182/blood.v77.11.2413.bloodjournal77112413.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Streszczenie:

Interleukin-6 (IL-6) is a multipotent lymphokine that can mediate differentiation of B cells into Ig-secreting cells, stimulate the growth of plasmacytomas, hybridomas, and T cells, and induce acute- phase proteins in liver cells. It has been suggested that IL-6 is involved in the pathogenesis of several diseases by autocrine or paracrine pathways. To examine whether IL-6 is possibly involved in the pathophysiology of Hodgkin's disease (HD), we analyzed the expression of IL-6 and IL-6 receptor mRNA and protein in cell lines and primary specimens from patients with HD. IL-6-specific transcripts were detected in three of six HD-derived cell lines by Northern blot analysis. In the culture supernatants of four HD-derived cell lines, IL- 6 was detected by radioimmunoassay. Biologic activity of IL-6 was confirmed by proliferation of an IL-6-dependent cell line. In situ hybridization experiments showed IL-6-specific transcripts in Hodgkin (H) and Reed-Sternberg (RS) cells in primary tissues of two patients. In addition, mRNAs specific for the IL-6 receptor were detected in five HD-derived cell lines. Immunostaining experiments showed expression of IL-6 receptor molecules on H and RS cells in 8 of 16 cases with HD. Thus, our data suggest that IL-6 might be involved in the pathophysiology of HD.

28

Plenz, Gabriele, Heike Eschert, Michael Erren, Thomas Wichter, Michael Böhm, Markus Flesch, Hans H. Scheld i Mario C. Deng. "The interleukin-6/interleukin-6-receptorsystem is activated in donor hearts". Journal of the American College of Cardiology 39, nr 9 (maj 2002): 1508–12. http://dx.doi.org/10.1016/s0735-1097(02)01791-6.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

29

Nancey, Stéphane, Nadim Hamzaoui, Driffa Moussata, Ivan Graber, Jacques Bienvenu i Bernard Flourie. "Serum Interleukin-6, Soluble Interleukin-6 Receptor and Crohn’s Disease Activity". Digestive Diseases and Sciences 53, nr 1 (5.06.2007): 242–47. http://dx.doi.org/10.1007/s10620-007-9849-6.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

30

Angelis, Pela, Simon Scharf, Alastair Mander, Frank Vajda i Nicholas Christophidis. "Serum interleukin-6 and interleukin-6 soluble receptor in Alzheimer's disease". Neuroscience Letters 244, nr 2 (marzec 1998): 106–8. http://dx.doi.org/10.1016/s0304-3940(98)00136-0.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

31

Rezai, Ali R., Ahmad Rezai, Otoniel Mart�nez-Maza, Meta Vander-Meyden i Martin H. Weiss. "Interleukin-6 and interleukin-6 receptor gene expression in pituitary tumors". Journal of Neuro-Oncology 19, nr 2 (czerwiec 1994): 131–35. http://dx.doi.org/10.1007/bf01306454.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

32

MONTERO-JULIAN, F. A., E. GAUTHEROT, J. WIJDENES, B. KLEIN i H. BRAILLY. "Pharmacokinetics of Interleukin-6 During Therapy with Anti-Interleukin-6 Monoclonal Antibodies: Enhanced Clearance of Interleukin-6 by a Combination of Three Anti-Interleukin-6 Antibodies". Journal of Interferon Research 14, nr 5 (październik 1994): 301–2. http://dx.doi.org/10.1089/jir.1994.14.301.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

33

KENIS, G., C. TEUNISSEN, R. DEJONGH, E. BOSMANS, H. STEINBUSCH i M. MAES. "STABILITY OF INTERLEUKIN 6, SOLUBLE INTERLEUKIN 6 RECEPTOR, INTERLEUKIN 10 AND CC16 IN HUMAN SERUM". Cytokine 19, nr 5 (wrzesień 2002): 228–35. http://dx.doi.org/10.1016/s1043-4666(02)91961-7.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

34

Kenis, Gunter, Charlotte Teunissen, Raf De Jongh, Eugène Bosmans, Harry Steinbusch i Michael Maes. "STABILITY OF INTERLEUKIN 6, SOLUBLE INTERLEUKIN 6 RECEPTOR, INTERLEUKIN 10 AND CC16 IN HUMAN SERUM". Cytokine 19, nr 5 (wrzesień 2002): 228–35. http://dx.doi.org/10.1006/cyto.2002.1961.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

35

HIRANO, TOSHIO. "Interleukin 6 (IL-6) and disease." Japanese Journal of Clinical Immunology 13, nr 5 (1990): 444–45. http://dx.doi.org/10.2177/jsci.13.444.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

36

Van Wagoner, N. J., i E. N. Benveniste. "Interleukin-6 regulation in human astrocytes: Synergy between TNF-alpha, interleukin-6, and the soluble-interleukin-6 receptor-alpha". Journal of Neuroimmunology 90, nr 1 (wrzesień 1998): 53. http://dx.doi.org/10.1016/s0165-5728(98)91497-7.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

37

Hoejberg, Lise, Lars Bastholt i Henrik Schmidt. "Interleukin-6 and melanoma". Melanoma Research 22, nr 5 (październik 2012): 327–33. http://dx.doi.org/10.1097/cmr.0b013e3283543d72.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

38

Rose-John, Stefan. "Interleukin-6 Family Cytokines". Cold Spring Harbor Perspectives in Biology 10, nr 2 (15.06.2017): a028415. http://dx.doi.org/10.1101/cshperspect.a028415.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

39

Tanaka, Toshio, Masashi Narazaki i Tadamitsu Kishimoto. "Interleukin (IL-6) Immunotherapy". Cold Spring Harbor Perspectives in Biology 10, nr 8 (4.08.2017): a028456. http://dx.doi.org/10.1101/cshperspect.a028456.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

40

Suzuki, Kenshi, Akiko Miyashita, Yasuyuki Inoue, Seiko Iki, Hidetoshi Enomoto, Yuji Takahashi i Tamiko Takemura. "Interleukin-6-Producing Pheochromocytoma". Acta Haematologica 85, nr 4 (1991): 217–19. http://dx.doi.org/10.1159/000204897.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

41

Kerr, Ron, David Stirling i Christopher A. Ludlam. "Interleukin 6 and Haemostasis". British Journal of Haematology 115, nr 1 (październik 2001): 3–12. http://dx.doi.org/10.1046/j.1365-2141.2001.03061.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

42

Sehgal, Pravinkumar B. "Interleukin-6: Molecular Pathophysiology". Journal of Investigative Dermatology 94, nr 6 (czerwiec 1990): s2—s6. http://dx.doi.org/10.1111/1523-1747.ep12874963.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

43

Van Snick, Jacques. "Interleukin-6: An Overview". Annual Review of Immunology 8, nr 1 (kwiecień 1990): 253–78. http://dx.doi.org/10.1146/annurev.iy.08.040190.001345.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

44

Pedersen, Bente Klarlund, Adam Steensberg i Peter Schjerling. "Exercise and interleukin-6". Current Opinion in Hematology 8, nr 3 (maj 2001): 137–41. http://dx.doi.org/10.1097/00062752-200105000-00002.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

45

Patarca, Roberto, i Mary Ann Fletcher. "Interleukin-6 and Disease". Journal of Chronic Fatigue Syndrome 4, nr 1 (styczeń 1998): 53–69. http://dx.doi.org/10.1300/j092v04n01_07.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

46

SEHGAL, PRAVIN B., LING WANG, RAVI RAYANADE, HENG PAN i LOLA MARGULIES. "Interleukin-6-Type Cytokinesa". Annals of the New York Academy of Sciences 762, nr 1 (17.12.2006): 1–14. http://dx.doi.org/10.1111/j.1749-6632.1995.tb32309.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

47

Mehra, Reena. "Soluble Interleukin 6 Receptor". Archives of Internal Medicine 166, nr 16 (18.09.2006): 1725. http://dx.doi.org/10.1001/archinte.166.16.1725.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

48

Henkin, Robert I., Loren Schmidt i Irina Velicu. "Interleukin 6 in Hyposmia". JAMA Otolaryngology–Head & Neck Surgery 139, nr 7 (1.07.2013): 728. http://dx.doi.org/10.1001/jamaoto.2013.3392.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

49

Tesch, H., M. Jüjcler, S. Klein, H. Abts, A. Güjnther, G. R. F. Krueger i V. Diehl. "Hodgkin and Reed-Sternberg Cells Express Interleukin 6 and Interleukin 6 Receptors". Leukemia & Lymphoma 7, nr 4 (styczeń 1992): 297–303. http://dx.doi.org/10.3109/10428199209049781.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

50

Peters, Malte, Guido Blinn, Thomas Jostock, Peter Schirmacher, Karl–Hermann Meyer Zum Büschenfelde, Peter R. Galle i Stefan Rose–John. "Combined interleukin 6 and soluble interleukin 6 receptor accelerates murine liver regeneration". Gastroenterology 119, nr 6 (grudzień 2000): 1663–71. http://dx.doi.org/10.1053/gast.2000.20236.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Artykuły w czasopismach na temat „Interleukin-6”

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych